Submitted:
11 December 2024
Posted:
12 December 2024
You are already at the latest version
Abstract
The spread of methicillin-resistant Staphylococcus aureus (MRSA) in community settings, including fitness/exercise centers, remains relevant for public health. MRSA, a cause for severe infections in some, can be transmitted through shared equipment and skin contact. Understanding its prevalence and the frequency of antibiotic resistance in such environments can be useful for informing hygiene and intervention strategies. For this investigation, multiple environmental swabs were collected from 14 different sites within a fitness facility, including equipment and locker rooms. Samples were collected to characterize the prevalence of staphylococci (including MRSA), E. coli, and carbapenem-resistant enterococci (CRE). Isolated colonies were identified biochemically and evaluated for antibiotic resistance. Logistic regression was applied to assess risk across different surfaces. Among 42 samples, the highest prevalence of Staphylococcus spp. was found on locker room surfaces. S. aureus was prevalent on locker room floors and benches. Non-S. aureus species, such as S. saprophyticus and S. haemolyticus, were common. Resistance to oxacillin and penicillin was widespread, particularly among non-S. aureus species. E. coli were detected once, and CRE were not detected. Fitness center surfaces can harbor staphylococci, including MRSA. This facility, and probably others, have notable antibiotic resistance among other staphylococci. Hygiene improvements, including personal hygiene actions, are essential for reducing transmission risks.
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Location and Description
2.2. Sample Collection and Culture-Based Methods
2.3. Staphylococci Species Identification and Antibiotic Susceptiblity Testing
2.4. Data Analysis
3. Results
3.1. Positive Detections for Staphylococcus spp. and E. coli on Sampled Surfaces
3.2. Associations between Surface Types and Likelihood of Recovering Presumable S. aureus and non-S. aureus
3.3. Antibiotic Resistance among Isolated Colonies Recovered from HardyChrom Chromogenic MRSA Agar
4. Discussion
4.1. Comparing the Prevalence of Staphylococci and Fecal Indicator Bacteria in Fitness Center Environments
4.2. Comparing the Prevalence of Antibiotic Resistance and MRSA Prevalence in Fitness Environments
4.3. Antibiotic Resistance among the Coagulase-Negative Staphylococci: A Growing Concern Beyond MRSA
4.4. Future Studies and Public Health Implications
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kourtis, A.P. , Staphylococcus aureus bloodstream infections in the United States, 2017: Surveillance trends and associated outcomes. J. Clin. Infect. Dis., 2019, 69, 1719–1724. [Google Scholar]
- Champion, E. , Goodwin, A., Brolinson, G., Were, R., Prater, M., Inzana, J., Prevalence and characterization of methicillin-resistant Staphylococcus aureus isolates from healthy university student athletes. Ann. Clin. Microbiol. Antimicrob., 2014, 13, 33. [Google Scholar] [CrossRef] [PubMed]
- Keller, M.B. , Turco, R.F., Gray, M.B., Sigler, V., The fate of methicillin-resistant Staphylococcus aureus in a synthetic turf system. Sports Health, 2020, 12, 263–270. [Google Scholar] [CrossRef]
- Dalman, M. , Bhatta, S., Nagajothi, N., Thapaliya, D., Olson, H., Naimi, H., Smith, T., Characterizing the molecular epidemiology of Staphylococcus aureus across and within fitness facility types. BMC Infect. Dis., 2019, 19, 69. [Google Scholar] [CrossRef] [PubMed]
- Gorwitz, R.J. , Kruszon-Moran, D., McAllister, S.K., McQuillan, G., McDougal, L.K., Fosheim, G.E., Jensen, B.J., Killgore, G., Tenover, F.C., Kuehnert, M.J., Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J. Infect. Dis., 2008, 197, 1226–1234. [Google Scholar] [CrossRef] [PubMed]
- Yang, L. , Dharmaratne, P., Zhu, C., Sapugahawatte, D.N., Rahman, N., Barua, N., Li, C., Kwok, K.O., Luo, M., Liyanapathirana, V., Ip, M., Global epidemiology of asymptomatic colonization of methicillin-resistant Staphylococcus aureus in the upper respiratory tract of young children: A systematic review and meta-analysis. Arch. Dis. Child., 2024, 109, 267–274. [Google Scholar] [PubMed]
- Dulon, M. , Peters, C., Schablon, A., Nienhaus, A., MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: A systematic review. BMC Infect. Dis., 2014, 14, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Ryan, K.A. , Ifantides, C., Bucciarelli, C., Saliba, H., Tuli, S., Black, E., Thompson, L.A., Are gymnasium equipment surfaces a source of staphylococcal infections in the community? Am. J. Infect. Control, 2011, 39, 148–150. [Google Scholar] [CrossRef]
- Markley, J. , Edmond, M., Major, Y., Bearman, G., Stevens, M., Are gym surfaces reservoirs for Staphylococcus aureus? A point prevalence survey. Am. J. Infect. Control, 2012, 40, 1008–1009. [Google Scholar] [CrossRef]
- Schilcher, K. , Horswill, A.R., Staphylococcal biofilm development: Structure, regulation, and treatment strategies. Microbiol. Mol. Biol. Rev., 2020, 84, e00001-20. [Google Scholar] [CrossRef] [PubMed]
- Smith, J.T. , Andam, C.P., Extensive horizontal gene transfer within and between species of coagulase-negative Staphylococcus. Genome Biol. Evol., 2021, 13, evab206. [Google Scholar] [CrossRef] [PubMed]
- Zhang, M. , Ma, Y., Xu, H., Wang, M., Li, L., Surfaces of gymnastic equipment as reservoirs of microbial pathogens with potential for transmission of bacterial infection and antimicrobial resistance. Front. Microbiol., 2023, 14, 1182594. [Google Scholar] [CrossRef]
- Boggs, C. , Shiferawe, K., Karsten, E., Hamlet, J., Altheide, S.T., Marion, J.W., Evaluation of a tetracycline-resistant E. coli enumeration method for correctly classifying E. coli in environmental waters in Kentucky, USA. Pathogens, 2023, 12, 1090. [Google Scholar] [CrossRef] [PubMed]
- Francy, D.S. , Darner, R.A., Comparison of methods for determining Escherichia coli concentrations in recreational waters. Water Res., 2000, 34, 2770–2778. [Google Scholar] [CrossRef]
- Beckman Coulter. Conventional Panels. Available online: https://www.beckmancoulter.com/products/microbiology/conventional-panels (accessed on December 6, 2024).
- Clinical and Laboratory Standards Institute (CLSI). Part B: CLSI vs. FDA Breakpoints. Available online: https://clsi.org/media/wxwfzvpd/part_b_clsi_vs_fda-breakpoints.xlsx (accessed on December 6, 2024).
- Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: March 2023; M100, ED33: Vol. 43, No. 3. Clinical Laboratory Standards Institute: Wayne, PA, USA, 2023. [Google Scholar]
- Haghverdian, B.A. , Patel, N., Wang, L., Cotter, J.A., The sports ball as a fomite for transmission of Staphylococcus aureus. J. Environ. Health, 2018, 80, 8–13. [Google Scholar]
- Boa, T.T. , Rahube, T.O., Fremaux, B., Levett, P.N., Yost, C.K., Prevalence of methicillin-resistant staphylococci species isolated from computer keyboards located in secondary and post-secondary schools. J. Environ. Health, 2013, 75, 50–58. [Google Scholar] [PubMed]
- Bilung, L.M. , Tahar, A.S., Kira, R., Mohd Rozali, A.A., Apun, K., High occurrence of Staphylococcus aureus isolated from fitness equipment from selected gymnasiums. J. Environ. Public Health, 2018, 2018, 4592830. [Google Scholar] [CrossRef]
- Szulc, J. , Cichowicz, R., Gutarowski, M., Okrasa, M., Gutarowska, B., Assessment of dust, chemical, microbiological pollutants, and microclimatic parameters of indoor air in sports facilities. Int. J. Environ. Res. Public Health, 2023, 20, 1551. [Google Scholar] [CrossRef]
- Boonrattanakij, N. , Yomchinda, S., Lin, F.J., Bellotindos, L.M., Lu, M.C., Investigation and disinfection of bacteria and fungi in sports fitness centers. Environ. Sci. Pollut. Res., 2021, 28, 52576–52586. [Google Scholar] [CrossRef] [PubMed]
- Kelly, A.M. , Mathema, B., Larson, E.L., Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int. J. Antimicrob. Agents, 2017, 50, 127–134. [Google Scholar] [CrossRef] [PubMed]
- Hachich, E.M. , Di Bari, M., Christ, A.P.G., Lamparelli, C.C., Ramos, S.S., Sato, M.I.Z., Comparison of thermotolerant coliforms and Escherichia coli densities in freshwater bodies. Brazil. J. Microbiol., 2012, 43, 675–681. [Google Scholar] [CrossRef]
- Alonzo, L.F. , Jain, P., Hinkley, T., Clute-Reinig, N., Garing, S., Spencer, E., Dinh, V.T., Bell, D., Nugen, S., Nichols, K.P., Le Ny, A.L.M., Rapid, sensitive, and low-cost detection of Escherichia coli bacteria in contaminated water samples using a phage-based assay. Sci. Rep., 2022, 12, 7741. [Google Scholar] [CrossRef] [PubMed]
- Nowicki, S. , Delaurent, Z.R., de Villiers, E.P., Githinji, G., Charles, K.J., The utility of Escherichia coli as a contamination indicator for rural drinking water: Evidence from whole genome sequencing. PLoS One, 2021, 16, e0245910. [Google Scholar] [CrossRef]
- Lee, S. , Park, Y.J., Yoo, J.H., Kahng, J., Jeong, I.H., Kwon, Y.M., Han, K., Comparison of culture screening protocols for methicillin-resistant Staphylococcus aureus (MRSA) using a chromogenic agar (MRSA-Select). Ann. Clin. Lab. Sci., 2008, 38, 254–257. [Google Scholar]
- Thapaliya, D. , Taha, M., Dalman, M.R., Kadariya, J., Smith, T.C., Environmental contamination with Staphylococcus aureus at a large, Midwestern university campus. Sci. Total Environ., 2017, 599, 1363–1368. [Google Scholar] [CrossRef]
- Eltwisy, H.O.; Twisy, H.O.; Hafez, M.H.; Sayed, I.M.; El-Mokhtar, M.A. Clinical infections, antibiotic resistance, and pathogenesis of Staphylococcus haemolyticus. Microorganisms 2022, 10, 1130. [Google Scholar] [CrossRef] [PubMed]
- Rossi, C.C.; Ferreira, N.C.; Coelho, M.L.; Schuenck, R.P.; Bastos, M.D.C.D.F.; Giambiagi-deMarval, M. Transfer of mupirocin resistance from Staphylococcus haemolyticus clinical strains to Staphylococcus aureus through conjugative and mobilizable plasmids. FEMS Microbiol. Lett. 2016, 363, fnw121. [Google Scholar] [CrossRef] [PubMed]
- Hashemzadeh, M.; Dezfuli, A.A.Z.; Nashibi, R.; Jahangirimehr, F.; Akbarian, Z.A. Study of biofilm formation, structure, and antibiotic resistance in Staphylococcus saprophyticus strains causing urinary tract infection in women in Ahvaz, Iran. New Microbes New Infect. 2021, 39, 100831. [Google Scholar] [CrossRef] [PubMed]
- Qu, Y.; Daley, A.J.; Istivan, T.S.; Garland, S.M.; Deighton, M.A. Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation. Ann. Clin. Microbiol. Antimicrob. 2010, 9, 1–12. [Google Scholar] [CrossRef]
- Zhang, K.; Potter, R.F.; Marino, J.; Muenks, C.E.; Lammers, M.G.; Dien Bard, J.; Dingle, T.C.; Humphries, R.; Westblade, L.F.; Burnham, C.A.D.; Dantas, G. Comparative genomics reveals the correlations of stress response genes and bacteriophages in developing antibiotic resistance of Staphylococcus saprophyticus. MSystems 2023, 8, e00697-23. [Google Scholar] [CrossRef]
- Onyango, L.A.; Liang, J. Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes. Front. Cell. Infect. Microbiol. 2024, 14, 1380289. [Google Scholar] [CrossRef]
- Poudel, A.N.; Zhu, S.; Cooper, N.; Little, P.; Tarrant, C.; Hickman, M.; Yao, G. The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS ONE 2023, 18, e0285170. [Google Scholar] [CrossRef]
- Martins, K.B. , Ferreira, A.M., Mondelli, A.L., Rocchetti, T.T. and de S da Cunha, M.D. Evaluation of MALDI-TOF VITEK® MS and VITEK® 2 system for the identification of Staphylococcus saprophyticus. Future Microbiology, 2018; 13, 14, 1603–1609. [Google Scholar] [CrossRef]
- Jeon, K. , Kim, J.M., Rho, K., Jung, S.H., Park, H.S. and Kim, J.S., Performance of a machine learning-based methicillin resistance of Staphylococcus aureus identification system using MALDI-TOF MS and comparison of the accuracy according to SCC mec types. Microorganisms, 2022; 10, 10, 1903. [Google Scholar] [CrossRef]
- Elba, I. and Ivy, J.W. Increasing the post-use cleaning of gym equipment using prompts and increased access to cleaning materials. Behavior Analysis in Practice, 2018; 11, 390–394. [Google Scholar] [CrossRef]
- Meade, T. Disinfect the rec: Creating and implementing a disinfection campaign at gyms using the theory of planned behavior. Recreational Sports Journal, 2015; 39, 2, 157–169. [Google Scholar]
| Baird-Parker Media + |
HardyChrom MRSA Agar | E. coli + | CRE+ | ||
| Types of Surfaces | Pink + | Blue + | |||
| Locker Room | 24/24 (100) | 10/24 (42) | 20/24 (83) | 1/24 (4) | 0/0 (0) |
| Shower Area | 12/12 (100) | 2/12 (17) | 10/12 (83) | 0/0 (0) | 0/0 (0) |
| Locker/Shower Floor | 12/12 (100) | 5/12 (42) | 11/12 (92) | 0/0 (0) | 0/0 (0) |
| Leg Contact Area | 5/6 (83) | 1/6 (17) | 3/6 (50) | 0/0 (0) | 0/0 (0) |
| Flat Surfaces | 21/24 (88) | 7/24 (29) | 17/24 (71) | 0/0 (0) | 0/0 (0) |
| Locker Benches | 12/12 (100) | 3/6 (50) | 9/12 (75) | 1/12 (8) | 0/0 (0) |
| Men’s Locker Room | 12/12 (100) | 6/12 (50) | 10/12 (83) | 0/0 (0) | 0/0 (0) |
| Women’s Locker Room | 12/12 (100) | 4/12 (33) | 10/12 (83) | 1/12 (8) | 0/0 (0) |
| Crevice Surfaces | 2/3 (67) | 0/3 (0) | 1/3 (33) | 0/0 (0) | 0/0 (0) |
| Flat Surfaces | 21/24 (88) | 7/24 (29) | 17/24 (71) | 1/24 (4) | 0/0 (0) |
| Handle Surfaces | 2/3 (67) | 1/3 (33) | 1/3 (33) | 0/0 (0) | 0/0 (0) |
| Species (Abbreviation) | Total | Color on Chromogenic Media Plate (%) | |||
| Blue | White | Pink | Black | ||
| S. aureus (SA) | 11 | 1 (9.1) | 0 (0) | 9 (82.8) | 1 (9.1) |
| S. haemolyticus (SH) | 8 | 1 (12.5) | 7 (87.5) | 0 (0) | 0 (0) |
| S. saprophyticus (SSap) | 7 | 7 (100) | 0 (0) | 0 (0) | 0 (0) |
| S. epidermidis (SE) | 5 | 2 (40.0) | 1 (20.0) | 2 (40.) | 0 (0) |
| S. cohnii-cohnii (SCC) | 3 | 1 (33.3) | 2 (66.7) | 0 (0) | 0 (0) |
| S. hominis-homin (SHH) | 3 | 1 (33.3) | 2 (66.7) | 0 (0) | 0 (0) |
| Aerococcus viridans (AV) | 2 | 0 (0) | 1 (50.0) | 1 (50.0) | 0 (0) |
| S. simulans (SSim) | 2 | 0 (0) | 1 (50.0) | 1 (50.0) | 0 (0) |
| S. warneri (SW) | 2 | 0 (0) | 1 (50.0) | 1 (50.0) | 0 (0) |
| Very rare biotype | 2 | 1 (50.0) | 1 (50.0) | 0 (0) | 0 (0) |
| S. cohnii-urea (SCU) | 1 | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
| S. intermedius (SI) | 1 | 0 (0) | 1 (100) | 0 (0) | 0 (0) |
| S. sciuri (SSci) | 1 | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
| Sum of Non-S. aureus | 37 | 17 (45.9) | 16 (43.2) | 3 (8.1) | 1 (2.7) |
| Total (all species) | 48 | 18 (37.5) | 16 (33.3) | 13 (27.1) | 1 (2.1) |
| Types of Surfaces | cOR | 95% CI | p |
| Locker Room | 3.6 | 0.81–15.7 | 0.092 |
| Shower Area | 0.4 | 0.06–1.87 | 0.218 |
| Locker/Shower Floor | 2.0 | 0.48–8.00 | 0.346 |
| Leg Contact Area | 0.4 | 0.04–3.82 | 0.426 |
| Flat Surfaces | 0.8 | 0.22–3.07 | 0.773 |
| Locker Benches | 2.0 | 0.48–8.00 | 0.346 |
| Men’s Locker Room | 2.0 | 0.38–10.4 | 0.410 |
| Flat Surfaces | 2.0 | 0.22–3.07 | 0.773 |
| Handle Surfaces | 1.1 | 0.09–13.6 | 0.926 |
| Types of Surfaces | cOR | 95% CI | P |
| Locker Room | 4.0 | 0.97–16.6 | 0.056 |
| Shower Area | 2.5 | 0.46–13.6 | 0.290 |
| Locker/Shower Floor | 6.4 | 0.72–56.2 | 0.096 |
| Leg Contact Area | 0.3 | 0.06–2.00 | 0.224 |
| Flat Surfaces | 0.9 | 0.24–3.62 | 0.921 |
| Locker Benches | 1.3 | 0.28–5.89 | 0.746 |
| Men’s Locker Room | 0.8 | 0.12–8.56 | 1.000 |
| Crevice Surfaces | 0.2 | 0.01–2.11 | 0.169 |
| Flat Surfaces | 1.3 | 0.28–5 89 | 0.746 |
| Handle Surfaces | 0.2 | 0.01–2.11 | 0.169 |
| Antibiotic | Species Abbreviation (% resistant) | Among Alln = 46 | |||||
| SA | SH | SSap | SE | SCC | SHH | ||
| n = 11 | n = 8 | n = 7 | n = 5 | n = 3 | n = 3 | ||
| Ampicillin | 4 (36) | 5 (63) | 1 (14) | 5 (100) | 0 (0) | 0 (0) | 17 (37) |
| Azithromycin | 1 (9) | 5 (63) | 4 (57) | 1 (20) | 2 (67) | 2 (67) | 17 (37) |
| Cefoxitin | 1 (9) | 4 (50) | 2 (29) | 1 (20) | 0 (0) | 1 (33) | 9 (20) |
| Cefazolin | 0 (0) | 0 (0) | 1 (14) | 0 (0) | 0 (0) | 0 (0) | 1 (2) |
| Ceftaroline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Chloramphenicol | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ciprofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Clindamycin | 0 (0) | 0 (0) | 3 (38) | 0 (0) | 1 (33) | 0 (0) | 4 (8) |
| Daptomycin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Doxycycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Erythromycin | 2 (18) | 5 (63) | 4 (57) | 1 (20) | 2 (67) | 2 (67) | 18 (39) |
| Gentamicin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Levofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Linezolid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Minocycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Moxifloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Nitrofurantoin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (4) |
| Oxacillin | 1 (9) | 4 (50) | 7 (100) | 2 (40) | 2 (67) | 1 (33) | 27 (59) |
| Penicillin | 5 (45) | 6 (75) | 5 (71) | 5 (100) | 1 (33) | 2 (67) | 27 (59) |
| Rifampin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Synercid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Tetracycline | 0 (0) | 2 (25) | 0 (0) | 0 (0) | 1 (33) | 0 (0) | 3 (7) |
| Vancomycin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| AV | Ssim | SW | SCU | SI | SSci | |
| Antibiotic | n = 2 | n = 2 | n = 2 | n = 1 | n = 1 | n = 1 |
| Ampicillin | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (100) | 0 (0) |
| Azithromycin | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) |
| Cefoxitin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Cefazolin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ceftaroline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Chloramphenicol | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ciprofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Clindamycin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Daptomycin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Doxycycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Erythromycin | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) |
| Gentamicin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Levofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Linezolid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Minocycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Moxifloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Nitrofurantoin | 2 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Oxacillin | 2 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 1 (100) |
| Penicillin | 0 (0) | 0 (0) | 2 (100) | 0 (0) | 1 (100) | 0 (0) |
| Rifampin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Synercid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Tetracycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Vancomycin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
